INTRODUCTION
Long-term neurological effects are inherent to acute and chronic drug abuse and the complex phenomenon that results from interaction between a variety of biologic and molecular factors remains difficult to address. This is in part due to the absence of clear, long-term markers of drug use and to the limited models that investigate the whole process of drug abuse and addiction in specific brain areas. Besides none of these models reproduces all the human features, the usefulness of each one depends in large part on its validity as simulation of human behaviour. Many acute and chronic animal models associated with different paradigms are aimed at the determination of the involvement of neurotransmitters like serotonin, dopamine, noradrenaline, endocannabinoids, γ-aminobutyric acid (GABA) or glutamate in several brain areas, at the investigation of specific aspects of the drug effects or at the analysis of the drug addiction process, The behavioural paradigms of euphoria and rewarding effects, including self-stimulation, self-administration, and conditioned place-preference models, are mostly used for the identification of the neuronal pathways involved in addiction [1;2] . All addictive drugs facilitate dopamine transmission and produce alterations in other neurotransmitters. For example, repeated cocaine produces in the rat a marked dopamine and glutamate release in nucleus accumbens and other areas such as ventral tegmental area and striatum [3] and ectasy abuse results in increased serotonin, dopamine and noradrenaline release [4] . The animal model with self-administration by various routes (e.g., oral, intragastric, intravenous, intracranial) is still the gold standard for assessing the rewarding properties of drug abuse and is commonly used for the preclinical assessment of the abuse liability of new agents [5] . In this model, experimental animals, normally a rat or a monkey are tested in a chamber containing a lever. Animals are trained to perform an operant task and drug delivery is made 5/48 contingent on the performance of an operant response, typically lever pressing or nose poking. With this technique, normal animal behaviour (e.g., grooming, feeding and drinking) can be studied concurrently with drug self-administration, but not the complexity of the molecular events.
In recent years knockout mice have helped identify the proteins mostly in charge of a specific response or behaviour [6] . Mice lacking a specific receptor, transporter or enzyme are used to determine whether this molecule plays a key role in the acute response or the addiction process [7] . For example, mice lacking the µ receptor neither exhibit the behavioural effects nor become physically dependent when given opioids.
Reverse genetic approaches is also applied to identify the underlying molecular components. Thus, models lacking a dopamine transporter, noradrenaline transporter or vesicular monoamine transporter and exposed to psychostimulants, tricyclic antidepressants or reserpine present an enhanced behavioural response explained by the direct or indirect dopamine receptor activation Alcoholism, an example of polygenic disorder, depends on gene-environment interactions [8] . Its chronic ingestion alters multiple pathways and modifies the serotonin, nicotinic, γ-aminobutyric (GABA) A , N-methyl-D-aspartate (NMDA) and µ and δ receptors. The absence of alcohol self-administration behaviour in µ receptor-k.o mice has been determinant to strongly involve this receptor and clarify, in part, the addiction process.
The ventral tegmental area (VTA) is necessary for the processing of rewarding of drugs of abuse, where they rapidly potentiate excitatory synapses on dopaminergic neurons, and alter GABAergic synapses. However, whereas the nature of the main pathway initially involved, the function of proteins that regulate pre-and postsynaptic glutamate neurotransmission appears modified in several brain areas. To illustrate the key 6/48 participation of glutamatergic transmission in circuits involved in drug abuse, cocaine, amphetamine and ethanol molecular actions are considered in more details.
GLUTAMATE NEUROTRANSMISSION, REWARD CIRCUIT AND DRUGS OF

ABUSE
The involvement of interconnected circuits between prefrontal cortex, hippocampus, nucleus accumbens, VTA, and amygadala in the development of addiction and in the manifestation of addictive behaviours implies the participation of many neurotransmitters. These organized circuits have GABAergic, peptidergic and glutamateric outputs, and activation of glutamatergic synapses seems critical in the expression of addictive behaviours. Glutamatergic transmission accounts for up to 70% in the Central Nervous System (CNS), and there are glutamatergic projections and/or neurons expressing glutamate receptors in most circuitries, including the reward one.
Thus, VTA and its different targeted regions, like nucleus accumbens, amygdaloid complex and frontal cortex receive substantial glutamatergic input [9] . Modification of glutamatergic function, a mechanism central to neuronal plasticity, is involved in shortterm and long-term drug effects. In this way, activation of glutamatergic pathways is a critical point in the development of addictive behaviours for a variety of drugs including, cocaine, heroin, nicotine and alcohol. As such, glutamate mediates numerous effects of acute and chronic exposure to cocaine. For example, metabotropic glutamate receptor 5 that has the potential to directly regulate neurons is essential for cocaine selfadministration and behaviour [10] . Acute administration induces a redistribution of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and NMDA receptors in the VTA and a reduction of various ionotropic glutamate receptor (GluR) subunits expression, like the GluR3, GluR4 and NMDA receptor subunit 1 (NR1) in the nucleus 7/48 accumbens. This may be viewed as a compensatory mechanism of the increased synaptic glutamate caused by cocaine, especially after high doses (30mg/kg, i.p.) [11] .
Chronic administration results in behavioural sensitization to cocaine, with an increased responsiveness of the dopamine mesolimbic system to glutamate due to a specific increased responsiveness of AMPA receptors and an increased expression of GluR1 of the VTA [12;13] . Some authors have also found in this area a specific increase of NR1 [14;15] . Because of the numerous procedural differences, changes in other GluR subunit expression as an adaptative response to repeated cocaine administration or withdrawal are not conclusive [16;17] . Because modifications are only detected associated with behavioural signs of sensitization; lack of data in other circumstances may overlook subtle changes, such as an increased surface expression of AMPA receptor subunits that remain to be clearly established [18;19] . In addition, involvement of glutamatergic transmission in cocaine reward, reinforcement and reinstatement has been clearly established by direct glutamatergic fibber stimulation or blockade of NMDA and AMPA VTA receptors [20;21] . However, how each component of the glutamatergic synapse participates and adapts to cocaine repeated exposure remains to be deciphered.
Research with genetically modified mice currently in process may be the better choice to clarify the role of each proposed target. Preliminary results indicate a preponderant role of the Homer proteins in the behavioural sensitizing effects [22;23] . These proteins that link NMDA and metabotropic glutamate receptors (mGluR) with intracellular calcium stores might be reduced in cocaine reward behaviour.
As for cocaine, increased overflow of glutamate is associated with amphetamine exposure [24;25] . In this condition, modifications of AMPA and mGlu receptor conductance underlie the well-known increased expression of c-fos and Zif268, and phosphorylation of transcription factors [26;27] . mGluR also mediate VTA neuron 8/48 plasticity induced by amphetamine [28] . Glutamatergic neurotransmission has been correlated with the neurotoxic effects of high doses of amphetamine [29] . However, the marked differences in glutamatergic neurotransmission caused by acute and chronic amphetamine exposures rise several questions related the plasticity of the glutamatergic synapse [30] [31] [32] . These questions mostly concern how modification of neuronal responsiveness takes place, how reduction in NMDA receptor components is accompanied by short and long-lasting modifications in AMPA and mGluR receptors, and how astroglia participates of these modifications. Finally, more research is also needed to better understand the role of glutamate in the reinforcement and relapsebehaviour of amphetamine exposure.
Research on glutamatergic neurotransmission and ethanol abuse is present from the late 80-90. Before, ethanol increased membrane fluidity and potentation of GABAergic neurotransmission were considered as its two basic mechanisms of action. Presently, ethanol inhibition of NMDA receptors resulting in an up-regulation of various NMDA receptor subunits in a chronic ingest has been well established [33] [34] [35] . Thus, consistently, several NMDA receptor subunits (NR1, NR2A and NR2B) are increased in VTA, amygdala, cerebral cortex and hippocampus and support an increased conductance and cationic influx [36] [37] [38] . However, ethanol effects on glutamate overflow depends on its concentration: at low dose synaptic glutamate levels are increased, whereas they are reduced at high ethanol doses [39;40] . Astroglia has been suggested to participate in this paradoxical effect, but research is needed to clearly understand the underlying cellular and molecular mechanisms [41] . The same is true for the effects of withdrawal. Acute manifestations include increased synaptic glutamate and hyper-excitability whose intensity can reach seizure-like level [42;43] . One of the main questions to be presently answered by researchers is why these manifestations 9/48 increase in intensity after repeated withdrawal periods. This question relates with the elevated risk factor of cerebrovascular diseases such as stroke present in ethanol abuse [44;45] . Finally, exposure to ethanol during synaptogenesis of the developing CNS causes an important neuronal loss due to the pro-apoptotic effect of ethanol. As a result, the disruption of synaptic connections and massive neuronal death explain the diminished brain size and disturbances associated with the foetal alcohol syndrome. In rodents, this neuronal loss only requires a single low ethanol intoxication episode (80mg/dl-60min) to trigger neurodegeneration [46;47] . Besides its major interest, research of long-term effects of drug exposure on CNS maturation is presently limited by the available experimental models and required time of study.
EXCITOTOXICITY AND NEURODEGENERATION
In the early 1970s, Olney defined excitotoxicity as the neuropathological process triggered after over stimulation of excitatory amino acid receptors [48] . At present, excitotoxicity includes the concept of glutamate-mediated endogenous neurotoxicity;
i.e. the putative excitotoxicity when glutamate increases in the extracellular space [49] .
This concept is of interest because it presents the possibility of new strategies in pharmacological neuroprotection. It is generally accepted that excitotoxic injury to neurons results from excessive inward currents of Ca 2+ and Na + through glutamateoperated ion channels -i.e. kainate, NMDA, or AMPA receptors-, supplemented by release of Ca 2+ from intracellular stores subsequent to mGluR activation, leading to intracellular Ca 2+ overload [50] . Excitotoxicity also involves an imbalance of transmembrane Na + , Cl -and K + gradients, cell swelling [51] and formation of calcium precipitates in most CNS areas [52] [53] [54] . The complexity of the mechanisms involved in glutamatergic neurotransmission makes it already apparent that a number of 10/48 abnormalities, pre-synaptic, post-synaptic or glial, alone or in combination can be excitotoxic. For example, a loss of selectivity of ionotropic receptors [49] , or deficiencies in glial re-uptake of glutamate [55] are observed in lateral amyotrophic sclerosis. In drug abuse, synaptic glutamate dysfunctions contribute to explain phenomena such as the effectiveness of either a mGluR1, mGluR5 or NMDA antagonist to inhibit the up regulation of endoplasmic reticulum stress protein due to acute and chronic cocaine administration [3] .
Excessive glutamate-mediated excitation stands out as a critical factor common to neurodegeneration [49;50;56] . Neurodegeneration can start after an acute injury whose immediate effects depend on a diversity of Ca 2+ activated injuring and compensatory mechanisms. For example, opioid blockade of long-term potentiation of GABA Amediated transmission onto dopamine neurons in the VTA potentiates excitatory synapses [57] , and may activate a chronic on-going neurodegenerative process. This sustained over-stimulation of glutamatergic synapses also observed after high doses of methamphetamine results in an excitotoxic process with a decrease in NMDA receptor binding and dopamine striatal content [58] . In fact, long-term dopamine toxicity associated with methamphetamine abuse is directly caused by glutamate receptor overstimualtion [59] .
A link between intracellular calcium concentration ([Ca 2+ ] i ) increase, over-activation of excitatory amino acid receptors, and neuronal death has been established from data obtained in in vitro and in vivo models [60] [61] [62] . In animal models, excitotoxicity can be reproduced with low doses of glutamate agonist microinjections. Due to the high affinity of ionotropic glutamate receptors for specific agonists, NMDA, AMPA or kainate injected in non saturable conditions are able to trigger calcium-mediated 11/48 excitotoxicity in several rat brain areas and an on-going neurodegenerative process [63] . Calcium overloading in cytosol and mitochondria plays a critical role in neuronal injury (Fig 1. ), but the superfluous Ca 2+ also induces release of several intrinsic and extrinsic factors that activate processes to rescue neurons from death [64] [65] [66] [67] . [52;75] . X-ray microanalysis showed an electron-diffraction ring pattern which was characteristic of a crystalline structure similar to apatites [76] , and a Ca/P ratio of 1.3±0.2 of cytoplasmic deposits ( fig. 2 ), a ratio lower than the theoretical apatite value of 1.67. This ratio is also typical of biological crystals which do not have an ideal organization [71] . As biological hydroxyapatites, these deposits are similar to 13/48 those observed in several peripheral human tissues [77;78] . Therefore, calcification depends on the increase in intracellular inorganic phosphate (i.e. adenosine triphosphate (ATP) depletion) and, most importantly, on the degree of protein phosphorylation.
Thus, the Ca 2+ -binding-protein-dependent kinases and the activity of neurotrophic factor ultimately control calcification. 
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Together with Ca 2+ deposits, glutamate ionotropic receptor over-stimulation induces precipitation of uric acid and aluminosilicates, and the accumulation of sulphated mucosubstances [75] . The formation of these products may be related to the appearance of tissue compensatory mechanisms. Uric acid, the end product of adenosine and guanosine catabolism, increases after nucleic acid degradation, acts as antioxidant and protects mitochondria against glutamate-induced [Ca 2+ ] i increase [79] . Moreover, adenosine inhibits neurotransmitter release and a balance between excitatory and inhibitory neurotransmission may prevent glutamate excitotoxicity [80;81] .
Consequently, the concentration of uric acid increases during neurodegeneration [82] and 
Overstimulation, intracellular calcium increase and energy failure
The increase in [Ca 2+ ] i and the energetic loss can induce other interdependent mechanisms that underlie neuronal death, such as acidosis, ROS generation, and activation of proteases and endonucleases that trigger apoptotic death.
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Excitotoxicity induces acidosis in cells and in the extracellular space [90] . There are several mechanisms by which pH decreases during neuronal injury. Mitochondrial damage forces the cell to a shift from aerobic to anaerobic metabolism; as a result lactate is produced with the formation of two ATPs and the release of two protons.
After trauma and ischemia, extracellular lactate increases dramatically and the pH decreases. To ensure neuronal viability during and even after human hypoxia, glial glucose is oxidized only to lactate, which is rapidly transported into neurons for its complete oxidation [91] . Furthermore, H + also appears during some chemical reactions such as phospholipid hydrolysis. In parallel, Ca 2+ influx causes rapid cytoplasmic acidification through a) the activity of membrane Na + /H + exchanger to restore the Na + gradient, and b) the Ca 2+ -dependent displacement of protons bound to cytoplasmic anions [62] .
Oxidative stress produced by methamphetamine is reflected by increases in lipid peroxidation, oxidized proteins in striatum and hippocampus, and reduction in striatal glutathione [92;93] . These toxic effects are the direct result of over-stimulation of GluRs, with the resultant activation of calcium-activated proteins. Agents that protect glutamate overflow protect from subsequent striatal toxicity, despite increases in synaptic dopamine [59] . Although it was initially accepted that excitotoxicity leads to necrotic death, a wide continuous spectrum of situations between apoptosis and necrosis has been described [97] . The factors that determine the pattern of neuronal death seem to be the intensity of the lesion, the [Ca 2+ ] i and the cellular energy capacity [98] ; the apoptotic death is associated with a combination of all factors that results in a less severe injury. The cell then prevents the uncontrolled release of intracellular compounds (e.g. glutamate) and the subsequent inflammatory response of tissue. As ATP levels decrease, the necrotic process starts presenting a hybrid pattern of both neuronal deaths. These mechanisms include defenses that: a) decrease neuronal excitability, b) decrease glutamate accumulation in the synapse, c) limit calcium mobilization in the postsynaptic neuron and protect against calcium-dependent degenerative effects, and d) enhance neuronal energetic [99] .
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Control of neuronal excitability
Potassium channels are in charge of controlling the peak of action potentials, i. e. of the control of neuronal excitability. More than one hundred of genes encoding for proteins forming potassium channels have been described [100] . Within this heterogeneity two of those channels are proposed as defense against neuronal over-stimulation. Ca 2+ -activated potassium channels of small conductance (SK channels) are present in a wide range of excitable and non-excitable cells. On activation by low concentrations of Ca 2+ , their opening results in hyperpolarization of the membrane potential and changes in cellular excitability [101] . SK channels play a key role in the spike-frequency adaptation and mediate the after-hyperpolarization that causes the refractory period [102] . As potentiation of the after-hyperpolarization by excessive cytosolic calcium would dampen the excitability, SK channels are ideally suited to transduce the calcium mobilization central to excitotoxic injury into a protective, hyperpolarizing signal.
Other candidate to control cellular excitability during excitotoxicity is the ATPdependent potassium (K ATP ) channel, which opening in the hypothalamus is triggered by ATP depletion [103] in the hypothalamus. As a result, K ATP channels can translate the energy depletion induced by any over-stimulation into a protective hyperpolarisation response. Thus, two reliable consequences of excitotoxic insults, the mobilization of cytosolic calcium and the depletion of ATP, would serve to activate potassium channels and decrease neuronal excitability in the face of a receptor over-stimulation.
Decrease of synaptic accumulation of glutamate.
Given the toxic effects of glutamate, adaptations that act to decrease its synaptic accumulation can potentially be protective. A number of the protective mechanisms 22/48 against a receptor over-stimulation are conducted to inhibit glutamate release during insults, and some of them involve retrograde signaling of inhibitory neurotransmitters and neuromodulators. Thus, GABA, taurine and adenosine present a retaliatory activity that has shown neuroprotective properties during glutamate-mediated neuronal insults [99] . For example, GABAergic retrograde signaling in hippocampus is multisynaptic,
i.e. collaterals from glutamatergic pyramidal terminate on GABAergic interneurons which, in turn, inhibit glutamatergic neurons [104] . Astroglial taurine release during insults derived from potassium and water uptake decreases presynaptic neuronal excitability by increasing chloride influx [105] . Adenosine neuroprotective activity is accomplished through binding to A 1 adenosine receptors linked by G proteins to both calcium and potassium channels [106] . Extracellular adenosine concentration increases after any acute brain injury to exert its protective actions. In this situation, extracellular adenosine increase finally results in an enhancement of uric acid level. Uric acid, a potent antioxidant, preserves mitochondrial activity and acts as a neuroprotective agent against the rise in glutamate induced intracellular calcium concentration [75;79] Two astroglial sodium-dependent transporters remove synaptic glutamate and transform it into glutamine by means of glutamine synthetase and ATP hydrolysis [107;108] .
Glutamine is released and returns to presynaptic neurons, where glutaminase, present prominently in glutamatergic neurons, converts it back into glutamate [109] . The fine adaptation of the glutamate-glutamine cycle to neuronal activity and suffering is important to avoid excessive synaptic glutamate and neuronal death [110] [111] [112] .
Enhancement of taurine released from glial cells decreases presynaptic excitability by binding to the GABA A [113] and glycine [114] receptors. By means of these interactions, taurine can help maintain the hippocampal inhibitory tone. In this line, adenosine modulation of glutamate activity also extends to the other systems. An
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adenosine modulation of GABA activity has been proposed [81] . This hypothesis is supported by data showing that following ischemia, adenosine receptor agonists inhibit the cortical release of GABA. A reduction in glutamate turnover after adenosine A1 receptor blockade indicates that adenosine participates in the control of the glutamateglutamine cycle through the modulation of glutamate transport by astrocytes [81] . These studies unveil an interdependency of all these processes, which coordinated adaptation and even the crosslink between their specific pathways are necessary to ensure control of neuronal excitability and receptor over-stimulation.
Limitation of calcium mobilization and protection against calcium-dependent degenerative effects
When cellular calcium homeostasis is overloaded, i. e. the sequestration systems (Ca 2+ -binding proteins) are saturated and the extrusion ones are activated, Ca 2+ /Na + antiporters and mitochondrial Ca 2+ uniporter reduce intracytosolic calcium. When the first wave is stopped, Ca 2+ binding proteins release Ca 2+ , which is extruded by the high efficiency cytoplasmatic plasma membrane calcium ATPases. A similar process takes place in mitochondria, the nuclear envelope-endoplasmic-reticulum network, and secretory vesicles (Fig. 4 ). All these systems, which maintain Ca 2+ movements under homeostatic control, have a critical dependence on energy. Interplay between all of them constitutes a coordinated way to decrease the extent of calcium mobilization in response to glutamate. Calcium itself can mediate a negative feedback. Calcium-dependent activation of calcineurin and calmodulin can inhibit voltage-gated and NMDA-receptorgated calcium currents, respectively [99] .
24/48 Mitochondrial intake of Ca 2+ decreases its electrochemical gradient; the opening of the permeability transition pore also dissipates a considerable percentile of membrane potential allowing free circulation of many ions through pores, and all extrusion systems. To restore the loss of electrochemical gradient and global ATP consumption, a fine controlled temporal stimulation of the mitochondrial respiratory chain is required.
Any alteration of the energy metabolism affects Ca 2+ homeostasis and vice-versa [115;116] .
Calcium precipitation has been proposed as a putative free-energy defense that limit for calcium movements. Although the significance of cellular calcification is unknown, a number of points suggest that it is part of the compensatory mechanisms for excitotoxic 25/48 neurodegeneration. For example, the observation that mitochondria close to Ca 2+ concretions appear normal at the electron microscopy level supports this hypothesis [71] , despite the fact that mitochondrial dysfunction constitutes a primary event in NMDA-induced degeneration in cultured hippocampal neurons [117] . This hypothesis is also consistent with the finding that neurons undergoing prolonged stimulation of NMDA receptors can survive in the presence of [Ca 2+ ] i chelators. Very high levels of cytoplasmic Ca 2+ are not necessarily neurotoxic, and an effective uptake of this element into mitochondria is required to trigger NMDA-receptor-stimulated neuronal death [118] . Other results support this hypothesis. In rat globus pallidus, the AMPA-doseresponse study has shown a dose-dependent increase in calcification which was not accompanied by an increase in astrogliosis [63] . In hippocampus, AMPA induced a calcified area larger than the injured area. In this same structure, the selective adenosine-A2a-receptor antagonist 8-(3-chlorostyryl)-caffeine increased the NMDAinduced neuronal loss while calcification was decreased [54] . Thus, all these data indicate that Ca 2+ precipitation does not necessarily reflect neuronal death and that, as proposed for retinal excitotoxic damage [119] , besides Ca 2+ other factors such as Na + and Cl -influx, K + efflux and swelling induce excitotoxic neuronal damage.
Excessive [Ca 2+ ] i ultimately leads to the generation of ROS, cytoskeletal degradation and the misfolding of proteins. A number of adaptations delimit some of these adverse consequences. [99] . All these species can be eliminated by two antioxidant mechanisms:
a) molecules such as vitamin C, E, and A, selenium and glutathion; and b) several enzymes like superoxide dismutase, quinone reductase and, the most abundant, astroglial glutathion peroxidase. All of these systems are activated after an acute injury and many of them interfere with glutamate neurotramsmission [99] .
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Research on calcium precipitation and neuronal suffering is limited, besides the interest of future developments based on the easiness of its detection. For example, in vivo calcification detection would help identify amyloid plaque formation in Alzheimer's disease or stroke, characterize the localization and extension of brain damage after hypoxia-ischemia, and facilitate the follow-up of the lesion [120] .
Enhancement of neuronal energetics
Synaptic increase of glutamate level, when not coupled to a heightened energy production, renders neurons susceptible to death. Astrocyte uptake and recycling of synaptic glutamate, as glutamine, is a major pathway dependent on energy metabolism.
This dependency, not fully understood remains controversial. Under control conditions, the stoichiometric coupling of glutamatergic activity and glucose metabolism accounts for 80% of total cerebral glucose [91] . Part of this energy is needed for glutamate recycling in a coordinated process involving astrocytes and neurons, with 15% of brain oxidative metabolism contributed by astroglia [121] . Reduced energy availability leading to altered glutamate activity may thus be involved in apoptotic or necrotic neuronal death [87;122] . As revealed by nuclear magnetic resonance studies, glutamate uptake by astrocytes and its return to neurons as glutamine is a major metabolic pathway that reflects most of the cerebral glutamatergic activity [86;91;123] . Finally, the maintenance of lactate deshydrogenase activity in an excitotoxic hippocampal lesion with a 55% of neuronal loss [112] , may reflect an astrocyte adaptation to heightened lactate availability to neurons.
Some protective responses to over-stimulation target the energetic vulnerability. At this point, any progress to understand the astroglial contribution for neuronal energy metabolism will be crucial to explain some of these adaptative mechanisms. It is a 27/48
general agreement that an increase in glucose transport is protective in brain tissue following an insult. Several pieces of evidence have been reported supporting this statement. The described adaptative mechanisms include an increase in perfusion rate and recruitment of capillaries; stimulation of glial uptake of glucose and glycogenolysis, and an enhancement of glucose uptake and release of adenosine and lactate, increasing lactate metabolic pathway [99] . Thus, after an excitotoxic insult glia takes up glucose and converts it to lactate, which is delivered to neurons as an energy substrate [86] .
Uncoupling of the retaliatory systems and energy availability
The tuning between retaliatory system actions and energy metabolism constitutes a fine equilibrium in physiological conditions, but it can be broken by neuronal overstimulation and then participate of the evoked neurodegenerative process. For example, AMPA-microinjection in medial septum, induces a progressive cholinergic and
GABAergic loss associated to a long-term decline of the hippocampal functions [124;125] , and decreased glutamatergic activity. Other effects of this lesion imply modifications of adenosine and taurine transmissions, glutamate recycling and glucose metabolism [81;112] . With time, adenosine replaces GABA functions to avoid further excitotoxic damage when cholinergic and GABAergic processes are compromised.
The long-term septal lesion-induced neuronal loss in hippocampus is apoptotic with enhancement of neuronal glycolisis (Fig. 5 ). Together with a cleavage of caspase 3, a glutamate-glutamine cycle displacement towards glutamine production reduces glutamate synthesis [112] . In addition, synaptic glutamine is decreased, probably expelled to vessels, where it exerts a vasodilatory effect through nitric oxide synthesis inhibition [126] . In this situation the reduction in glutamate signaling and increased neuronal energy metabolism reflect a neurodegenerative process with a deficient 28/48 adaptation of the retaliatory systems and a chronic energy requirement to execute the apoptotic program. When an acute brain damage activates a neurodegenerative process its further progression will be related to the intensity of the initial injury. An on-going process with progressive neuronal loss may also be triggered by reiterative sustained neuronal over-stimulation. Acute neurological injury and chronic brain damage has been related in boxing participants, with a correlation in the prevalence of subdural hematoma and dementia pugilistica [127;128] . The same occurs with the disruption of the blood brain barrier induced by epileptic focus that triggers delayed neurodegeneration and functional brain impairment [129] . Cerebrovascular diseases and ischemia-reperfusion 30/48 processes might also be central in Alzheimer's disease pathogenesis [130] [131] [132] }. Longterm effects of drug dependence underlie an excitotoxicity process linked to a polysynaptic pathway that dynamically regulates synaptic glutamate, and subsequently its dysregulation with modifications of metabotropic, AMPA or NMDA receptor activity. The increased interest in glutamate-based strategies has evidenced promising results [133] . Clinical results with NMDA receptor antagonists such as memantine indicate a decrease of morphine intake in addict; promising results have also been obtained to treat withdrawal syndromes from opioids, alcohol and other sedatives [134] .
In addition, blockade of mGluR5 with methyl-6-phenylethymiyl-pyridine may help control the behavioural effects of cocaine, nicotine and alcohol [135] [136] [137] and argue for the presence of a chronic neurodegenerative process. However, as said elsewhere, the differences observed in the glutamatergic synapse components in response to acute or 4.-To get an integrated view of how a drug interferes the energy capability of neurons, the neuron-glia interactions and the inhibitory systems aimed at the control of acute and chronic over-stimulation.
